Find a Chapter

Funding for this trial has been provided in full or in part by Cystic Fibrosis Foundation Therapeutics, Inc.

Study Phase:

Other

Recruitment Status:

Trial Completed

Study Drug(s):

Multiple systemic antibiotics

Number of Participants Being Recruited:

130

Single / Multi-Center:

Multi-Center

STUDY BACKGROUND INFORMATION:

A biomarker is a biochemical or a substance in the body that can be used to measure disease activity or effects of treatment. There is a need to identify biomarkers in CF that can be used to more quickly evaluate potential new treatments. Pulmonary exacerbations provide a nice opportunity to define the effect of intravenous antibiotics on candidate biomarkers and to determine whether clinical improvements are related to changes in bloodstream biomarkers.

Note: Detailed eligibility criteria information may be available on clinicaltrials.gov. If a specific
trial listing for this trial is available, a link to the specific clinicaltrials.gov listing will be present in the "More Information" section below.